An "Innovative Poetry" of Laboratory Medicine in the Eternal City
When in Rome, Do as Romans do
Italy is the legacy of the ancient Roman civilization, which was the cradle of European culture. Inheriting the wisdom of Hippocrates and Galen, Salerno, the earliest medical school in Europe, was born in this land. To this day, Italy continues to lead the way in developing global medicine.
Following in the footsteps of medical giants such as Andreas Vesalius, Marcello Malpighi, and Maria Montessori, we joined more than ten of the world's leading experts in laboratory medicine at the Tusculum Hill Castle in the capital city of Rome to honor the legacy of our forefathers and talk about cutting-edge technological innovations.
Mindray and the experts discussed topics such as diagnosing and managing diseases, applying AI, the future direction of laboratory construction and development, and the technical focus of blood cells, biochemistry, and immunity.
Q: Why and how to establish reference ranges?
Prof. Khosrow Adeli
IFCC President
Senior Scientist
at the Hospital for Sick Children, University of Toronto
"There are many gaps in reference ranges for hematology, chemistry, and other areas. In collaboration with Mindray, we completed hematology range studies for 79 parameters and published them. Now, labs worldwide using Mindray instruments can benefit from the reference ranges."
Q: What are the opportunities for digitalization morphology?
Prof. Gina Zini
Associate Professor, Department of
Oncology and Hematology
Catholic University of the Sacred Heart - Gemelli Polyclinic Foundation, Italy
"With this strong technology, I'm sure that the next step is the application in the analysis of bone marrow fluids."
"As for the peripheral blood, the digitalization of the images helps the organization of diagnosis, the training, the reduce intra (and) inter-laboratory variability."
"And including the possibility to storage and to train (new fellows) with the images of those rare cases."
Q: What's the significance of laboratory automation for diagnosis and patients?
Dr. Tommaso Trenti
SIBioC President, ltaly
"At first is in use value in delivering timely and high-quality care to the patient."
"The main point is the value for patients in our care system. "
"In this way, by automation, we can improve efficiency in terms of the best use of laboratory resources, accuracy, and good test."
Q: What's the right attitude towards trending techs?
Prof. Dr. Tomris Ozben
EFLM President
IFCC President-elect
"Artificial intelligence might be seen as a new opportunity, but there must be some regulations because otherwise, they may also give some unpleasant results."
"We should be open to the developments, new technologies, but we should also be careful in applying them. The promise and potential for precision and personalized medicine."
"Clinicians should carefully evaluate and assess every patient with the help of laboratory data and laboratory medicine. Then all the treatments should be designed, tailored for patients. "
"We need to go towards personalized medicine, precision medicine. We should follow this and appraise with specific attention also to be paid to the contingency of the success on advanced information technology capabilities."
"We need to go towards personalized medicine, precision medicine. We should follow this and appraise with specific attention also to be paid to the contingency of the success on advanced information technology capabilities."
Think like Aurelius
Mindray has long established partnerships with hospitals and medical institutes globally to carry out clinical research and studies on disease diagnosis and management.
At the symposium, experts worldwide will share the latest and most advanced research findings in clinical diagnostics to the audience.
During the academic presentation, Prof. Emanuela R. Galliera from the University of Milan discussed using the novel sCD14-ST test in diagnosing osteoarticular infectious diseases. She highlighted the test's ability to provide valuable insights into disease severity, treatment monitoring, and prognosis in postoperative joint replacement infections.
Prof. Sergio Bernardini from the Tor Vergata University School of Medicine in Rome discussed the pros and cons of applying Al technology in medicine. He also highlighted the differences in big data analysis across disciplines and the associated challenges with practical implementation in the laboratory. In addition, Prof. Bernardini cited the example of digital morphology as an Al application in laboratory diagnostics and used the sepsis research collaboration between Mindray and Tor Vergata as an example of the successful implementation of this technology.
In the future, Mindray will continue to extend its innovative footsteps, write internationalized poems with world experts, give our answers to the future development of laboratory medicine, and let more people share quality life care.